Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Emanuelle Marie Rizk, M.D.

Concepts (73)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Melanoma11202255720.680 Why?
Lymphocytes, Tumor-Infiltrating3202110610.670 Why?
Immunotherapy4202245940.520 Why?
Skin Neoplasms6202356890.260 Why?
CD8-Positive T-Lymphocytes1201945180.250 Why?
Oncolytic Virotherapy220225050.240 Why?
Keratosis, Actinic12021710.180 Why?
Carcinoma, Basal Cell120235490.150 Why?
Oncolytic Viruses120223330.150 Why?
Skin2202143920.140 Why?
Adjuvants, Immunologic1202110250.130 Why?
Staining and Labeling1201910920.130 Why?
Prognosis62021290720.120 Why?
Tumor Microenvironment3202236980.110 Why?
Dermatology120239040.110 Why?
Image Processing, Computer-Assisted2202189040.110 Why?
Immunity120199960.110 Why?
Disease Susceptibility1201917600.100 Why?
Survival Rate32020126320.100 Why?
Biological Products120208850.090 Why?
Carcinoma, Pancreatic Ductal1202216720.090 Why?
Neoplasms12019216810.090 Why?
Gene Expression1202175790.080 Why?
Immunohistochemistry12019110370.060 Why?
Macrophages1202056480.060 Why?
Neoplasm Staging42021110640.060 Why?
Pancreatic Neoplasms1202252610.060 Why?
Biopsy3202167320.060 Why?
Neoplasm Recurrence, Local1201991720.050 Why?
Mohs Surgery120232040.050 Why?
Aged, 80 and over62021575520.050 Why?
Retrospective Studies72023782930.040 Why?
Dideoxynucleosides120201240.040 Why?
Kaplan-Meier Estimate2202164530.040 Why?
Administration, Topical120216880.040 Why?
Humans1420237460700.040 Why?
Antineoplastic Agents12022135310.040 Why?
HLA-DR Antigens120206300.040 Why?
Aged820211642220.040 Why?
Treatment Outcome22021636640.030 Why?
Young Adult52021571140.030 Why?
Middle Aged820212144190.030 Why?
Area Under Curve1201916010.030 Why?
Fluorescent Antibody Technique1202024730.030 Why?
Forkhead Transcription Factors1202215850.030 Why?
Herpesvirus 1, Human120207480.030 Why?
Tumor Burden1202018810.030 Why?
ROC Curve1202134960.030 Why?
T-Lymphocytes, Cytotoxic1202018000.030 Why?
Immunologic Factors1202215680.030 Why?
Chemotherapy, Adjuvant1202134760.030 Why?
Male820213510980.030 Why?
Proto-Oncogene Proteins B-raf1202220300.020 Why?
Adult620212149690.020 Why?
Female820213821290.020 Why?
Reactive Oxygen Species1201920630.020 Why?
Neoadjuvant Therapy1202227870.020 Why?
Patient Satisfaction1202334080.020 Why?
Referral and Consultation1202335420.020 Why?
Radiopharmaceuticals1202026540.020 Why?
Algorithms22019137980.020 Why?
Risk Assessment22021234540.020 Why?
Patient Selection1202141920.020 Why?
Follow-Up Studies22021387520.020 Why?
Image Interpretation, Computer-Assisted1201933060.020 Why?
Risk Factors22023724130.020 Why?
Predictive Value of Tests12020150100.010 Why?
Gene Expression Profiling1201993130.010 Why?
Disease Progression12019133020.010 Why?
Prospective Studies12023532190.010 Why?
Mice12022800650.010 Why?
Adolescent12019862120.010 Why?
Animals120221663080.010 Why?
Rizk's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (73)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.